South Africa side­lines As­traZeneca's vac­cine af­ter it failed to pro­tect against new vari­ant in a study, rais­ing glob­al alarms

South Africa is slam­ming the brakes on the roll­out of As­traZeneca and Ox­ford Uni­ver­si­ty’s Covid-19 vac­cine af­ter da­ta showed it did not pro­tect against mild …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.